The combined vaccine elicited higher immune response against SARS-CoV-2.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
In the first large study looking at SARS-CoV-2 viral loads (VL) in asymptomatic children, researchers found that VL were 3 to 4 logs lower compared with symptomatic children, which was consistent with the difference in median cycle threshold (Ct) values—10.3 cycles—between the two groups.
The therapy provided no benefit over usual care in 464 COVID-19 adult patients.
Gilead says the approval is based on results of 3 randomized controlled trials.
The study also found that those with Down syndrome had 5 times the risk of hospitalization.
A paper published yesterday in the Morbidity and Mortality Weekly Report highlights a case study the Centers for Disease Control and Prevention (CDC) has used to update how it defines close contacts of people infected with SARS-CoV-2, the virus that causes COVID-19.
Experts call for a move from a "fail and fix" approach to a "predict and prevent" paradigm.
The past week has seen nearly 60,000 US cases a day on average and 700 deaths.
And US officials might be missing almost 200,000 COVID-19 deaths.
A study yesterday in Infection Control & Hospital Epidemiology found that individuals with mild or no COVID-19 symptoms may be infectious for no more than about 10 days, while those with severe illness may be able to spread the virus for as long as 20 days. The infectious periods align with US Centers for Disease Control and Prevention (CDC) recommendations for isolation time.
Trust in institutions and leaders seems to affect how likely people will be to accept COVID-19 vaccination.
